AMERICAN LASERS, INC. K061850
510() SUMMARY OF SAFETY AND EFFECTIVENESS SEP 2 9 2006
MINL-YAG LASER
IN ACCORADANCE WITH THE SAKE MEDICAL DEVICES ACT OF 1990, 21CFR 807,92, THE
FOLLOWING IS A SUMMARY OF THE SAFETY AND EFFECTIVENESS INFORMATION ON
WHICH THE SUBSTANTIAL EQUIVALENCE
DETERMINATION IS BASED.
THE SAFETY AND EFFECTIVENESS OF THE MINI-VAG LASER DERIVES FROM A
DETERMINATION OF SUBSTANTIAL EQUIVALENCE TO THE PREDICATE DEVICES
LISTED BELOW.
APPLICANT: AMERICAN LASERS, INC.
300 EAST MAIN STREET
ALHAMBRA, CA 91801 :
C/O DAVID K. QUON, PRESIDENT .
DATE PREPARED: SEPTEMBER 22, 2006
MODEL:
TRADE NAME: MINI-YAG LASER
COMMON NAME: Q-SWITCHED Nd:YAG LASER WITH FREQUENCY DOUBLER.
PRODUCT CODE: GEX .
PANEL: 79
C.B.R. SECTION; 878.4810
CLASSIFICATION PANEL: GENERAL AND PLASTIC SURGERY.
CLASSIFICATION:
MEDICAL DEVICE CLASS: REGULATORY CLASS If
LASER SAFETY CLASS: CLASS IV LASER PRODUCT
PREDICATE DEVICES:
PALOMAR Q-YAG LASER SYSTEM (K023967)
MEDLITE Q-SWITCHED Nd:YAG LASER (022709 & K983054) .
MEDLITE C3 O- SWITCHED Ni: ¥AG LASER (011677)
MEDLITE C6 Q-SWITCHED Nd:YAG LASER (K014234)
SPHCTRA-VRM Q-SWITCHED Nd:YAG LASER (K000317)
LIGHT AGE Q-CLEAR LASER (K033259)
DESCRIPTION:
THE MINI_YAG LASER IS A Nd:YAG LASER WITH EMITTED WAVELENGTH AT 1064
NANOMETERS. WIL THE FREQUENCY DOUBLER INSTALLED, A 532 NANOMETER
WAVELENGTH IS EMITTED. THE 1064 NM IS IN THE NEAR-INFRARED PORTION OF THE
SPECTRUM, WHILE THE 532 NM IS VISIBLE AS A GREEN LIGHT. LASER ENERGY IS
DELIVERED DIRECTLY TO THE SKIN LESION VIA THE HANDPIECE, WHICH PRODUCES
A CIRCULAR BEAM GN THE SKIN. THE SUINI-YAG LASER IS EQUIPPED WITL SAFETY
FEATURES IN CONFORMANCE WITH 21CFR PART 1040.

INTENDED USES:

1, FOR INCISION, EXCISION, ABLATION, AND VAPORIZATION OF SOFT TISSUE FOR
GENERAL DERMATOLOGY.

2, THE 1064 NM WAVELENCTH IS INDICATED FOR:
DARK INK TATTOO REMOVAL.
‘TREATMENT OF PIGMENTED LESIONS SUCH AS NEVUS Gf OTA.

REMOVAL OR LIGHTENING OF HAIR.
TREATMENT OF COMMON NEVL

3. THE 532 NM WAVELENGTH IS INDICATED FOR:
REMOVAL OF LIGHT INK (RED, TAN, PURPLE, AND ORANGE) TATTOOS
TREATMENT OF COMMON NEV}.
TREATMENT OF CAFE -AU-LAIT SPOTS. .
TREATMENT OF SEBORRHEIC KERATOSES
TREATMENT OF VASCULAR LESIONS, INCLUDING FACIAL AND LEG VEINS,
‘TELENGLECTASIAS, ANGIOMAS, HEMANGIOMAS, PORT-WINE STAINS, AND
MOST PIGMENTED LESINS SUCH AS LENTIGINES, AND EPHELIDES.
SARETY AND KEFECTIVENESS:
THE MIN)}-YAG LASER FROM AMERICAN LASERS, INC. HAS THE SAME
WAVELENGTHS, THE SAME SPOT SIZE, THE SAME PRINCIPLE OF OPERATION,
ESSENTIALLY THE SAME FLUENCE LEVELS, AND THE SAME INTENDED USE AS
THE PREDICATE DEVICES. THE MINI-YAG LASER BUES NOT KAISE NEW
QUESTIONS OF SAFETY OR EFFECTIVENESS, AND IS SUBSTANTIALLY
EQUIVALENT TO THE PREDICATE DEVICES LISTED ABOVE.

|
= ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a I i Waa
“hase Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
American Lasers, Inc. SEP 29 2006
% Mr. David K. Quon, MD
President .
300 East Main Street
Alhambra, California 91801
Re: K061850
Trade/Device Name: Mini-Yag
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology
Regulatory Class: II
Product Code: GEX
Dated: June 28, 2006
Received: July 31, 2006
Dear Dr. Quon:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28. 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may,
therefore. market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
, manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into erther class IT (Special Controls) or class {1 (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA‘s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part
807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the
quality systems (QS) regulation (21 CFR Part 820). and if applicable, the electronic product
radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 ~ Mr. David K. Quon, MD - -- oO
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain other
general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free numbér (800) 638-2041 or ~~
(240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely rs,

| ew 0

Mark N. Melkerson

Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

Indications for Use ,
510(k) Number (if known): 061850 .
Device Name: MINI-YAG
Indications Forse; WRAL AG lah SEBASYSTEMEROMAMERICAN LASERS.INC.IS A SOLID-STATE-. +.
Nd:YAG LASER SYSTEM THAT PROVIDES TWO WAVELENGTHS, 1064nm AND
$32nm FOR THE REMOVAL OF BLACK AND BLUE TATTOOS AS WELL AS
SUPERFICIAL SPIDERMAL PIGMENTED LESIONS AND SMALL VASCULAR
LESIONS,
TATTOOS REMOVAL:
‘THE S32am WAVELENGTH CAN BE USED ‘10 REMOVE RED, TAN, PURPLE,
AND ORANGE TATTOO INKS.
THE 1064am WAVELENGTH CAN BE USED TO REMOVE DARK (BLACK) AND
BLUE COLOR INKS.
THE 532nm WAVELENGTH CAN ALSO BL USLD FOR REMOVAL OL SUPLRUICAL
BENIGN, PIGMENTED SKIN LESIONS SUCH AS LENTIGINES AND CAFE-AU-LAIT,
TREATMENT OF COMMON NEVI, AND SEBORRHEIC KERATOSES.
ALSO ‘THE 532am WAVELENGTH CAN BE USED TO REMOVE SMALL VASCULAR
LESIONS SUCH AS TELAGIECTASIAS, SMALL FACIAL AND LEG VEINS,
ANGIOMAS, HEMANGIOMAS, PORT-WINE STAINS, AND MOST OTHER BENIGN
PIGMENTED LESIONS SUCH AS LENTIGINES AND EPHELIDES.
THR 10fdnm WAVAI-ENGTH CAN Al SQ RE USER. TO TREAT PIGMENTED L.ASIONS
SUCH AS THE NEVUS OF OTA, REMOVAL OR LIGHTENING OF HAR,
_. TREATMENT OF COMMON NEV, ——————________-____: Prescription Use _**——"_ARDIOR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) {21 CFR 801 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of C Office of Device Evaluation (ODE)
(Division SignDivision of General, Restorative, 1
‘ 5 Page 1 of
and Neurological Devices 9 —_
Lol) HY
510(k) Number. —_

